Epigenomics' FY 2010 Revenues Fall 58 Percent

The firm's revenues were down due to non-recurring revenue in 2009 tied to R&D support for partners.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories